{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:25:59Z","timestamp":1768307159972,"version":"3.49.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2040328","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:24:42Z","timestamp":1648833882000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination"],"prefix":"10.1080","volume":"18","author":[{"given":"Jean-Etienne","family":"Poirrier","sequence":"first","affiliation":[{"name":"GSK, US Health Outcomes and Epidemiology, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"DeMartino","sequence":"additional","affiliation":[{"name":"GSK, US Health Outcomes and Epidemiology, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Nagar","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Health Economics, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-9309","authenticated-orcid":false,"given":"Justin","family":"Carrico","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Health Economics, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1058-3401","authenticated-orcid":false,"given":"Katherine","family":"Hicks","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Health Economics, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Meyers","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Health Economics, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Stoddard","sequence":"additional","affiliation":[{"name":"GSK, US Health Outcomes and Epidemiology, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,4]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Centers for Disease Control and Prevention. Shingles overview. 2018 [accessed 2018 Jan 18 2019]. https:\/\/www.cdc.gov\/shingles\/about\/overview.html"},{"key":"e_1_3_6_3_1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz R","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. 2008;57:1\u201311.","journal-title":"Mmwr"},{"key":"e_1_3_6_4_1","unstructured":"Centers for Disease Control and Prevention. Complications of Shingles. 2019 [accessed 2020 June 6]. https:\/\/www.cdc.gov\/shingles\/about\/complications.html"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.01.014"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0011-2"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-012-0014-3"},{"key":"e_1_3_6_9_1","first-page":"S9","article-title":"Chronic pain perspectives: Treating herpes zoster and postherpetic neuralgia: an evidence-based approach","volume":"61","author":"Thakur R","year":"2012","unstructured":"Thakur R, Philip AG. Chronic pain perspectives: Treating herpes zoster and postherpetic neuralgia: an evidence-based approach. J Fam Pract. 2012;61:S9\u201315.","journal-title":"J Fam Pract"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2017.07.016"},{"key":"e_1_3_6_11_1","unstructured":"Department of Health and Human Services (HHS). 5-Point strategy to combat the opioid crisis. 2020 [accessed 2020 Sep 15]. https:\/\/www.hhs.gov\/opioids\/about-the-epidemic\/hhs-response\/index.html"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-012-0030-4"},{"key":"e_1_3_6_13_1","volume-title":"Academy of Managed Care Pharmacy\u02bbs Nexus Meeting","author":"Shukla S","year":"2017","unstructured":"Shukla S, Wiggall A, Jan S Assessing opioid trends and management of members with general pain conditions. Academy of Managed Care Pharmacy\u02bbs Nexus Meeting; Dallas, TX, USA. 2017."},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.03.1018"},{"key":"e_1_3_6_15_1","volume-title":"AAFP Family Medicine Experience (FMX)","author":"Suaya JA","year":"2017","unstructured":"Suaya JA Zoster costs in US adults with diabetes. AAFP Family Medicine Experience (FMX). San Antonio, TX, USA, 2017."},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw067"},{"key":"e_1_3_6_17_1","unstructured":"GlaxoSmithKline Inc. SHINGRIX (Zoster vaccine recombinant adjuvanted). Prescribing Inf. 2019."},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_6_20_1","unstructured":"IBM Watson Health. IBM market scan research databases for life sciences researchers. 2018 [accessed 2020 Sep 15]. https:\/\/www.ibm.com\/downloads\/cas\/0NKLE57Y"},{"key":"e_1_3_6_21_1","first-page":"1432","article-title":"Herpes zoster and postherpetic neuralgia: prevention and management","volume":"83","author":"Fashner J","year":"2011","unstructured":"Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2011;83:1432\u201337.","journal-title":"Am Fam Physician"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.01.006"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1324373"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.11.079"},{"key":"e_1_3_6_26_1","first-page":"439","article-title":"Quasi-Likelihood functions, generalized linear models, and the Gauss-Newton method","volume":"61","author":"Wedderburn RWM","year":"1974","unstructured":"Wedderburn RWM. Quasi-Likelihood functions, generalized linear models, and the Gauss-Newton method. Biometrika. 1974;61:439\u201347.","journal-title":"Biometrika"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1653"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1345399"},{"key":"e_1_3_6_29_1","unstructured":"Patterson B Herring WL van Oorschot D Curran D Carrico J Zhang Y et al. Public health and economic impact of adjuvanted recombinant Zoster vaccine adoption for a large integrated delivery network: utilizing real\u2010World epidemiological data in a budget impact model. National Harbor MD: Academy of Managed Care Pharmacy (AMCP) Nexus; 2019."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa439.1182"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6610a1"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.04.012"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0665"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303568"},{"key":"e_1_3_6_36_1","unstructured":"National Conference of State Legislatures. Prescribing policies: states confront opioid overdose epidemic. 2019 [cited 2021 Jul 15]."},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1406143"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1243"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3365"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0013628"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.005"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2040328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T21:16:07Z","timestamp":1707167767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2040328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2040328"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2040328","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2040328"}}